$SINT
Sintx Technologies, Inc. Stock $sint

$sint Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000149315224044728 Filed on November 12, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue		$799.0K
YoY Change		17.85%
Cost Of Revenue		$210.0K
YoY Change		79.49%
Gross Profit		$589.0K
YoY Change		4.99%
Gross Profit Margin		73.72%
Selling, General & Admin		$889.0K
YoY Change		-28.82%
% of Gross Profit		150.93%
Research & Development		$796.0K
YoY Change		-68.48%
% of Gross Profit		135.14%
Depreciation & Amortization		$212.0K
YoY Change		-24.29%
% of Gross Profit		35.99%
Operating Expenses		$6.997M
YoY Change		67.59%
Operating Profit		-$6.408M
YoY Change		77.31%
Interest Expense		$188.0K
YoY Change		-54.15%
% of Operating Profit
Other Income/Expense, Net		$169.0K
YoY Change		-60.14%
Pretax Income		-$6.239M
YoY Change		95.58%
Income Tax
% Of Pretax Income
Net Earnings		-$6.239M
YoY Change		95.58%
Net Earnings / Revenue		-780.85%
Basic Earnings Per Share		-$6.96
Diluted Earnings Per Share		-$6.96
COMMON SHARES
Basic Shares Outstanding	1.343M shares	747.3K shares
Diluted Shares Outstanding		897.3K shares

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$4.814M
YoY Change		-22.6%
Cash & Equivalents		$4.814M
Short-Term Investments
Other Short-Term Assets		$120.0K
YoY Change		185.71%
Inventory		$500.0K
Prepaid Expenses
Receivables		$340.0K
Other Receivables		$0.00
Total Short-Term Assets		$6.332M
YoY Change		-19.97%
LONG-TERM ASSETS
Property, Plant & Equipment		$1.048M
YoY Change		-80.95%
Goodwill
YoY Change
Intangibles		$17.00K
YoY Change		-22.73%
Long-Term Investments
YoY Change
Other Assets		$235.0K
YoY Change		183.13%
Total Long-Term Assets		$4.971M
YoY Change		-34.59%
TOTAL ASSETS
Total Short-Term Assets		$6.332M
Total Long-Term Assets		$4.971M
Total Assets		$11.30M
YoY Change		-27.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$153.0K
YoY Change		-68.19%
Accrued Expenses		$1.099M
YoY Change		-37.13%
Deferred Revenue
YoY Change
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due		$134.0K
YoY Change		86.11%
Total Short-Term Liabilities		$2.080M
YoY Change		-44.94%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change
Other Long-Term Liabilities		$3.642M
YoY Change
Total Long-Term Liabilities		$3.642M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities		$2.080M
Total Long-Term Liabilities		$3.642M
Total Liabilities		$5.722M
YoY Change		18.64%
SHAREHOLDERS EQUITY
Retained Earnings		-$280.0M
YoY Change		4.32%
Common Stock		$13.00K
YoY Change		-69.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		$5.581M
YoY Change
Total Liabilities & Shareholders Equity		$11.30M
YoY Change		-27.13%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		-$6.239M
YoY Change		95.58%
Depreciation, Depletion And Amortization		$212.0K
YoY Change		-24.29%
Cash From Operating Activities		-$2.570M
YoY Change		-11.99%
INVESTING ACTIVITIES
Capital Expenditures		$11.00K
YoY Change		-91.54%
Acquisitions
YoY Change
Other Investing Activities		-$20.00K
YoY Change		-200.0%
Cash From Investing Activities		-$31.00K
YoY Change		-71.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		2.858M
YoY Change		-3275.56%
NET CHANGE
Cash From Operating Activities		-2.570M
Cash From Investing Activities		-31.00K
Cash From Financing Activities		2.858M
Net Change In Cash		257.0K
YoY Change		-108.24%
FREE CASH FLOW
Cash From Operating Activities		-$2.570M
Capital Expenditures		$11.00K
Free Cash Flow		-$2.581M
YoY Change		-15.38%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Interest Expense Other InterestExpenseOther	15000	usd
	us-gaap	Interest Expense Other InterestExpenseOther	2000	usd
CY2024Q3	us-gaap	Interest Income Other InterestIncomeOther	24000	usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-33624
	dei	Entity Registrant Name EntityRegistrantName	SINTX Technologies, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-1375299
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1885 West 2100 South
	dei	Entity Address City Or Town EntityAddressCityOrTown	Salt Lake City
	dei	Entity Address State Or Province EntityAddressStateOrProvince	UT
	dei	Local Phone Number LocalPhoneNumber	839-3500
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	SINT
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1342853	shares
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4814000	usd
CY2024Q3	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	340000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	595000	usd
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	120000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	6332000	usd
CY2024Q3	us-gaap	Inventory Noncurrent InventoryNoncurrent	403000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1048000	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	17000	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	235000	usd
CY2024Q3	us-gaap	Assets Assets	11303000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	153000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1099000	usd
CY2024Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	134000	usd
CY2024Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	224000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	469000	usd
CY2024Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2080000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	5722000	usd
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	13000	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	285611000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-280043000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	5581000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11303000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5704000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	86000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	4457000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	383000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3642000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	799000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	678000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2345000	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	210000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	117000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	657000	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	589000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	561000	usd
	us-gaap	Gross Profit GrossProfit	1688000	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	796000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2525000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4492000	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	802000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	990000	usd
CY2024Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	87000	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	259000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	589000	usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001269026
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue		usd
CY2023Q3	us-gaap	Business Exit Costs1 BusinessExitCosts1		usd
	us-gaap	Business Exit Costs1 BusinessExitCosts1		usd
CY2023Q3	us-gaap	Severance Costs1 SeveranceCosts1		usd
	us-gaap	Severance Costs1 SeveranceCosts1		usd
CY2023Q3	us-gaap	Interest Expense Other InterestExpenseOther		usd
CY2024Q3	SINT	Offering Costs Associated With Derivative Warrant Liabilities OfferingCostsAssociatedWithDerivativeWarrantLiabilities		usd
CY2023Q3	SINT	Offering Costs Associated With Derivative Warrant Liabilities OfferingCostsAssociatedWithDerivativeWarrantLiabilities		usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
CY2023Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
CY2024Q3	SINT	Basic Deemed Dividend And Accretion Of Discount On Conversion Of Series B Preferred Stock BasicDeemedDividendAndAccretionOfDiscountOnConversionOfSeriesBPreferredStock
CY2023Q3	SINT	Basic Deemed Dividend And Accretion Of Discount On Conversion Of Series B Preferred Stock BasicDeemedDividendAndAccretionOfDiscountOnConversionOfSeriesBPreferredStock
	SINT	Basic Deemed Dividend And Accretion Of Discount On Conversion Of Series B Preferred Stock BasicDeemedDividendAndAccretionOfDiscountOnConversionOfSeriesBPreferredStock
CY2024Q3	SINT	Diluted Deemed Dividend And Accretion Of Discount On Conversion Of Preferred Stock DilutedDeemedDividendAndAccretionOfDiscountOnConversionOfPreferredStock
CY2023Q3	SINT	Diluted Deemed Dividend And Accretion Of Discount On Conversion Of Preferred Stock DilutedDeemedDividendAndAccretionOfDiscountOnConversionOfPreferredStock
	SINT	Diluted Deemed Dividend And Accretion Of Discount On Conversion Of Preferred Stock DilutedDeemedDividendAndAccretionOfDiscountOnConversionOfPreferredStock
CY2023Q1	SINT	Stock Issued During Period Value Exercise Of Prefunded Warrants For Cash StockIssuedDuringPeriodValueExerciseOfPrefundedWarrantsForCash		usd
CY2023Q1	SINT	Stock Issued During Period Value Cashless Exercise Of Warrants StockIssuedDuringPeriodValueCashlessExerciseOfWarrants		usd
CY2023Q1	SINT	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits		usd
CY2023Q2	SINT	Stock Issued During Period Value Cashless Exercise Of Warrants StockIssuedDuringPeriodValueCashlessExerciseOfWarrants		usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2024Q1	SINT	Stock Issued During Period Value Exercise Of Prefunded Warrants For Cash StockIssuedDuringPeriodValueExerciseOfPrefundedWarrantsForCash		usd
CY2024Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2024Q2	SINT	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits		usd
CY2024Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
	SINT	Proceeds From Issuance Of Common Stock Exercise Of Warrants ProceedsFromIssuanceOfCommonStockExerciseOfWarrants		usd
	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock		usd
	SINT	Debt Issued For Prepaid Insurance DebtIssuedForPrepaidInsurance		usd
	SINT	Agent Warrant Offering Cost Allocated To Equity AgentWarrantOfferingCostAllocatedToEquity		usd
	SINT	Right Of Use Asset For New Lease Liability RightOfUseAssetForNewLeaseLiability		usd
	SINT	Par Value Of Common Stock Upon Cashless Exercise Of Warrants ParValueOfCommonStockUponCashlessExerciseOfWarrants		usd
	SINT	Par Value Of Common Stock Upon Exercise Of Prefunded Warrants ParValueOfCommonStockUponExerciseOfPrefundedWarrants		usd
CY2023Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
CY2023Q3	SINT	Deemed Dividend And Accretion Of Discounts Effect Of Dilutive Warrant Securities DeemedDividendAndAccretionOfDiscountsEffectOfDilutiveWarrantSecurities		usd
CY2023Q3	SINT	Deemed Dividend And Accretion Of Discount Diluted Calculation DeemedDividendAndAccretionOfDiscountDilutedCalculation		usd
	SINT	Deemed Dividend And Accretion Of Discount Effect Of Dilutive Warrant Securities DeemedDividendAndAccretionOfDiscountEffectOfDilutiveWarrantSecurities
CY2023Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
CY2023Q3	SINT	Deemed Dividend And Accretion Of Discounts Effect Of Dilutive Warrant Securities DeemedDividendAndAccretionOfDiscountsEffectOfDilutiveWarrantSecurities		usd
CY2023Q3	SINT	Deemed Dividend And Accretion Of Discount Diluted Calculation DeemedDividendAndAccretionOfDiscountDilutedCalculation		usd
CY2023Q3	SINT	Basic Deemed Dividend And Accretion Of Discount Basic Calculation BasicDeemedDividendAndAccretionOfDiscountBasicCalculation
CY2023Q3	SINT	Deemed Dividend And Accretion Of Discount Effect Of Dilutive Warrant Securities DeemedDividendAndAccretionOfDiscountEffectOfDilutiveWarrantSecurities
CY2023Q3	SINT	Dilutive Deemed Dividend And Accretion Of Discount Diluted Calculation DilutiveDeemedDividendAndAccretionOfDiscountDilutedCalculation
	SINT	Deemed Dividend And Accretion Of Discounts Effect Of Dilutive Warrant Securities DeemedDividendAndAccretionOfDiscountsEffectOfDilutiveWarrantSecurities		usd
	SINT	Deemed Dividend And Accretion Of Discount Effect Of Dilutive Warrant Securities DeemedDividendAndAccretionOfDiscountEffectOfDilutiveWarrantSecurities
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue		usd
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	84119
	dei	City Area Code CityAreaCode	(801)
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.01
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3340000	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	84000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	72000	usd
CY2023Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	685000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	539000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	463000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	888000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	80000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	5532000	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	333000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4826000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	21000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3268000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4094000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	559000	usd
CY2023Q4	us-gaap	Assets Assets	15365000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	636000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1404000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	46000	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	304000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	512000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2906000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3687000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	6593000	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1342853	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1342853	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26603	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26603	shares
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	279486000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-270714000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8772000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15365000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1725000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	339000	usd
	us-gaap	Gross Profit GrossProfit	1386000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6889000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2997000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3313000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	877000	usd
CY2024Q3	us-gaap	Business Exit Costs1 BusinessExitCosts1	4457000	usd
	us-gaap	Business Exit Costs1 BusinessExitCosts1	4457000	usd
CY2024Q3	us-gaap	Severance Costs1 SeveranceCosts1	407000	usd
	us-gaap	Severance Costs1 SeveranceCosts1	407000	usd
CY2024Q3	SINT	Grant And Contract Expenses GrantAndContractExpenses	448000	usd
CY2023Q3	SINT	Grant And Contract Expenses GrantAndContractExpenses	401000	usd
	SINT	Grant And Contract Expenses GrantAndContractExpenses	1061000	usd
	SINT	Grant And Contract Expenses GrantAndContractExpenses	942000	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	6997000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	4175000	usd
	us-gaap	Operating Expenses OperatingExpenses	14003000	usd
	us-gaap	Operating Expenses OperatingExpenses	12021000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-6408000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3614000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12315000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-10635000	usd
CY2024Q3	us-gaap	Interest Expense Other InterestExpenseOther	9000	usd
CY2023Q3	us-gaap	Interest Income Other InterestIncomeOther	33000	usd
	us-gaap	Interest Income Other InterestIncomeOther	66000	usd
	us-gaap	Interest Income Other InterestIncomeOther	117000	usd
CY2024Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-20000	usd
CY2023Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	17000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-8000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	17000	usd
CY2024Q3	SINT	Change In Fair Value Of Derivative Liabilities ChangeInFairValueOfDerivativeLiabilities	173000	usd
CY2023Q3	SINT	Change In Fair Value Of Derivative Liabilities ChangeInFairValueOfDerivativeLiabilities	374000	usd
	SINT	Change In Fair Value Of Derivative Liabilities ChangeInFairValueOfDerivativeLiabilities	3459000	usd
	SINT	Change In Fair Value Of Derivative Liabilities ChangeInFairValueOfDerivativeLiabilities	5344000	usd
	SINT	Offering Costs Associated With Derivative Warrant Liabilities OfferingCostsAssociatedWithDerivativeWarrantLiabilities	550000	usd
	SINT	Offering Costs Associated With Derivative Warrant Liabilities OfferingCostsAssociatedWithDerivativeWarrantLiabilities	786000	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	34000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7000	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	169000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	424000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2986000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4697000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6239000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3190000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9329000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5938000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-6239000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-3190000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-9329000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5938000	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	26000	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6239000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3190000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9329000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5964000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-6.96
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-151.61
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-17.30
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-336.99
	SINT	Basic Deemed Dividend And Accretion Of Discount On Conversion Of Series B Preferred Stock BasicDeemedDividendAndAccretionOfDiscountOnConversionOfSeriesBPreferredStock	-1.48
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.96
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-151.61
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-17.30
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-338.47
CY2024Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-6.96
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-161.21
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-19.59
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-605.90
	SINT	Diluted Deemed Dividend And Accretion Of Discount On Conversion Of Preferred Stock DilutedDeemedDividendAndAccretionOfDiscountOnConversionOfPreferredStock	-1.47
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.96
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-161.21
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-19.59
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-607.37
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	896305	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21040	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	539252	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17621	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	897323	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21996	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	656468	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17642	shares
CY2023Q1	SINT	Stock Issued During Period Value Extinguishment Of Derivative Liabilities Upon Exercise Of Warrants StockIssuedDuringPeriodValueExtinguishmentOfDerivativeLiabilitiesUponExerciseOfWarrants	5502000	usd
CY2023Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-2000	usd
CY2023Q1	SINT	Adjustments To Additional Paid In Capital Issuance Of Agent Warrants AdjustmentsToAdditionalPaidInCapitalIssuanceOfAgentWarrants	108000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-293000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	15945000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	71000	usd
CY2023Q2	SINT	Stock Issued During Period Value Extinguishment Of Derivative Liabilities Upon Exercise Of Warrants StockIssuedDuringPeriodValueExtinguishmentOfDerivativeLiabilitiesUponExerciseOfWarrants	251000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-26000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	26000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2455000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	13812000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	67000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-3190000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	10689000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8772000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	50000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1584000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	406000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-886000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	9926000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1108000	usd
CY2024Q2	SINT	Stock Issued During Period Value Extinguishment Of Derivative Liabilities Upon Exercise Of Warrants StockIssuedDuringPeriodValueExtinguishmentOfDerivativeLiabilitiesUponExerciseOfWarrants	1000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2204000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	8846000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	8846000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	10000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	2964000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-6239000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	5581000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	5581000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-9329000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5938000	usd
	us-gaap	Depreciation Depreciation	727000	usd
	us-gaap	Depreciation Depreciation	645000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	4457000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	428000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	560000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	75000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	224000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	3459000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	5237000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-8000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	17000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	13000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	53000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-332000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-15000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-241000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	231000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-171000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	328000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-788000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	176000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-2000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-370000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-396000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-543000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7518000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10987000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	544000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	456000	usd
	SINT	Proceeds From Notes Receivable Net Of Imputed Interest ProceedsFromNotesReceivableNetOfImputedInterest	320000	usd
	SINT	Proceeds From Notes Receivable Net Of Imputed Interest ProceedsFromNotesReceivableNetOfImputedInterest	17000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	20000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-204000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-439000	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	3366000	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	6650000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6075000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4840000	usd
	SINT	Proceeds From Issuance Of Common Stock Exercise Of Warrants ProceedsFromIssuanceOfCommonStockExerciseOfWarrants	2000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	247000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	88000	usd
	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	2000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9196000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	11400000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1474000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-26000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3340000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6245000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4814000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6219000	usd
	SINT	Debt Issued For Prepaid Insurance DebtIssuedForPrepaidInsurance	335000	usd
	SINT	Right Of Use Asset For Amended Lease Liability RightOfUseAssetForAmendedLeaseLiability	307000	usd
	SINT	Right Of Use Asset For Amended Lease Liability RightOfUseAssetForAmendedLeaseLiability	-88000	usd
	SINT	Agent Warrant Offering Cost Allocated To Equity AgentWarrantOfferingCostAllocatedToEquity	13000	usd
	SINT	Reduction Of Derivative Liability Upon Exercise Of Warrants ReductionOfDerivativeLiabilityUponExerciseOfWarrants	1000	usd
	SINT	Reduction Of Derivative Liability Upon Exercise Of Warrants ReductionOfDerivativeLiabilityUponExerciseOfWarrants	5753000	usd
	SINT	Right Of Use Asset For New Lease Liability RightOfUseAssetForNewLeaseLiability	114000	usd
	SINT	Par Value Of Common Stock Upon Cashless Exercise Of Warrants ParValueOfCommonStockUponCashlessExerciseOfWarrants	15000	usd
	SINT	Par Value Of Common Stock Upon Exercise Of Prefunded Warrants ParValueOfCommonStockUponExerciseOfPrefundedWarrants	2000	usd
	us-gaap	Interest Paid Net InterestPaidNet	15000	usd
	us-gaap	Interest Paid Net InterestPaidNet	2000	usd
CY2024Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	4500000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-9300000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5900000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7500000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11000000.0	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-280000000.0	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-270700000	usd
CY2023Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	10750	shares
CY2024Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	80000	shares
CY2024Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	50.00
CY2024Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	142000	shares
CY2024Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	9.40
CY2024Q1	SINT	Offering Expenses Payable OfferingExpensesPayable	1300000	usd
CY2024Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	358000	shares
CY2024Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	4.20
CY2024Q2	SINT	Offering Expenses Payable OfferingExpensesPayable	1500000	usd
CY2024Q2	SINT	Minimum Bid Price MinimumBidPrice	1.00
CY2024Q2	SINT	Minimum Bid Price MinimumBidPrice	1.00
CY2024Q3	us-gaap	Severance Costs1 SeveranceCosts1	400000	usd
CY2024Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	4500000	usd
CY2024Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	4500000	usd
CY2024Q2	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1 for 200 reverse stock split
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_843_eus-gaap--UseOfEstimates_zCrfGS2AU7Ia" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_z3pLVANRB55i">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the period. Actual results could differ from those estimates. As of September 30, 2024, the most significant estimate relates to derivative liabilities relating to common stock warrants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies State And Local EffectiveIncomeTaxRateReconciliationTaxContingenciesStateAndLocal	0.05	pure
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	71000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6000	shares
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-6239000	usd
CY2024Q3	SINT	Net Income Effect Of Dilutive Warrant Securities NetIncomeEffectOfDilutiveWarrantSecurities	-4000	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-6243000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3190000	usd
CY2023Q3	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	-356000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3546000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	896305	shares
CY2024Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1018	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	897323	shares
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-336.99
	SINT	Net Loss Effect Of Dilutive Warrant Securities Per Share NetLossEffectOfDilutiveWarrantSecuritiesPerShare	-230239.88
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-605.90
	SINT	Basic Deemed Dividend And Accretion Of Discount Basic Calculation BasicDeemedDividendAndAccretionOfDiscountBasicCalculation	-1.48
	SINT	Dilutive Deemed Dividend And Accretion Of Discount Diluted Calculation DilutiveDeemedDividendAndAccretionOfDiscountDilutedCalculation	-1.47
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.96
CY2024Q3	SINT	Net Income Effect Of Dilutive Warrant Securities Per Share NetIncomeEffectOfDilutiveWarrantSecuritiesPerShare	-3.93
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.96
	us-gaap	Net Income Loss NetIncomeLoss	-9329000	usd
	SINT	Net Income Effect Of Dilutive Warrant Securities NetIncomeEffectOfDilutiveWarrantSecurities	-3530000	usd
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-12859000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	539252	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	117216	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	656468	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-17.30
	SINT	Net Income Effect Of Dilutive Warrant Securities Per Share NetIncomeEffectOfDilutiveWarrantSecuritiesPerShare	-30.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-19.59
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-3190000	usd
CY2023Q3	SINT	Net Income Effect Of Dilutive Warrant Securities NetIncomeEffectOfDilutiveWarrantSecurities	-356000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-3546000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3190000	usd
CY2023Q3	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	-356000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3546000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21040	shares
CY2023Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	956	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21996	shares
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-151.61
CY2023Q3	SINT	Net Loss Effect Of Dilutive Warrant Securities Per Share NetLossEffectOfDilutiveWarrantSecuritiesPerShare	-372.38
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-161.21
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-151.61
CY2023Q3	SINT	Net Income Effect Of Dilutive Warrant Securities Per Share NetIncomeEffectOfDilutiveWarrantSecuritiesPerShare	-372.38
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-161.21
	us-gaap	Net Income Loss NetIncomeLoss	-5938000	usd
	SINT	Net Income Effect Of Dilutive Warrant Securities NetIncomeEffectOfDilutiveWarrantSecurities	-4751000	usd
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-10689000	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	26000	usd
	SINT	Deemed Dividend And Accretion Of Discount Diluted Calculation DeemedDividendAndAccretionOfDiscountDilutedCalculation	-26000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5964000	usd
	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	-4751000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-10715000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17621	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	21	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17642	shares
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-336.99
	SINT	Net Loss Effect Of Dilutive Warrant Securities Per Share NetLossEffectOfDilutiveWarrantSecuritiesPerShare	-230239.88
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-605.90
	SINT	Basic Deemed Dividend And Accretion Of Discount Basic Calculation BasicDeemedDividendAndAccretionOfDiscountBasicCalculation	-1.48
	SINT	Dilutive Deemed Dividend And Accretion Of Discount Diluted Calculation DilutiveDeemedDividendAndAccretionOfDiscountDilutedCalculation	-1.47
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-338.47
	SINT	Net Income Effect Of Dilutive Warrant Securities Per Share NetIncomeEffectOfDilutiveWarrantSecuritiesPerShare	-230239.88
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-607.37
CY2024Q3	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	527000	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	691000	usd
CY2024Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	152000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	426000	usd
CY2024Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	187000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	104000	usd
CY2024Q3	SINT	Inventory Total InventoryTotal	866000	usd
CY2023Q4	SINT	Inventory Total InventoryTotal	1221000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	500000	usd
CY2024Q3	us-gaap	Inventory Noncurrent InventoryNoncurrent	400000	usd
CY2024Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	224000	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	304000	usd
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	496000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	610000	usd
CY2024Q3	SINT	Accrued Payable Current AccruedPayableCurrent	93000	usd
CY2023Q4	SINT	Accrued Payable Current AccruedPayableCurrent	163000	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	510000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	631000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1099000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1404000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	60	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	21954
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y10M24D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	13000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	26749000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	1	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	891768343
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	46	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	19969
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y10M24D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	45	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	26105
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y3M18D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	22	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	29359
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y9M18D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	60	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	46800
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y10M24D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	60	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	24000
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y2M12D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	48	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	59800
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y2M12D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	49	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	24000
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y2M12D
CY2024Q3	us-gaap	Area Of Land AreaOfLand	30764	sqft
	us-gaap	Lessee Operating Lease Option To Extend LesseeOperatingLeaseOptionToExtend	The lease has one five-year extension option.
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3300000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	4100000	usd
	SINT	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	400000	usd
	SINT	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	600000	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.088	pure
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	208000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	790000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	748000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	770000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	794000	usd
CY2024Q3	SINT	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	2241000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	5551000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1439000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	4111000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	469000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3642000	usd

Files In Submission

Name	View Source	Status
0001493152-24-044728-index-headers.html	Edgar Link	pending
0001493152-24-044728-index.html	Edgar Link	pending
0001493152-24-044728.txt	Edgar Link	pending
0001493152-24-044728-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
sint-20240930.xsd	Edgar Link	pending
sint-20240930_cal.xml	Edgar Link	unprocessable
sint-20240930_def.xml	Edgar Link	unprocessable
sint-20240930_lab.xml	Edgar Link	unprocessable
sint-20240930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SINT
Sintx Technologies, Inc. Stock $sint

2024 Q4 Form 10-Q Financial Statement

#000149315224044728 Filed on November 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SINT Sintx Technologies, Inc. Stock $sint

2024 Q4 Form 10-Q Financial Statement

#000149315224044728 Filed on November 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SINT
Sintx Technologies, Inc. Stock $sint